FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16635011000001105: Olanzapine pamoate monohydrate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    58884101000001112 Olanzapine pamoate monohydrate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    60831701000001118 Olanzapine embonate monohydrate en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Olanzapine pamoate monohydrate Is a Olanzapine false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Olanzapine 210mg powder and solvent for suspension for injection vials Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Olanzapine 300mg powder and solvent for suspension for injection vials Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Olanzapine 405mg powder and solvent for suspension for injection vials Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Zypadhera 210mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Zypadhera 300mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Zypadhera 405mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Olanzapine 405mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Olanzapine 300mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Olanzapine 210mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Zypadhera 210mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Zypadhera 300mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier
    Zypadhera 405mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient False Olanzapine pamoate monohydrate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start